Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023)

Historic Amortization of Deferred Charges for AVITA Medical (RCEL) over the last 3 years, with Q4 2023 value amounting to $86000.0.

  • AVITA Medical's Amortization of Deferred Charges rose 117.65% to $86000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $341000.0, marking a year-over-year increase of 6238.1%. This contributed to the annual value of $341000.0 for FY2023, which is 88.76% up from last year.
  • As of Q4 2023, AVITA Medical's Amortization of Deferred Charges stood at $86000.0, which was up 117.65% from $85000.0 recorded in Q3 2023.
  • In the past 5 years, AVITA Medical's Amortization of Deferred Charges registered a high of $86000.0 during Q4 2023, and its lowest value of -$42000.0 during Q2 2022.
  • In the last 3 years, AVITA Medical's Amortization of Deferred Charges had a median value of $85000.0 in 2022 and averaged $68000.0.
  • In the last 5 years, AVITA Medical's Amortization of Deferred Charges crashed by 15316.46% in 2022 and then surged by 30238.1% in 2023.
  • Over the past 3 years, AVITA Medical's Amortization of Deferred Charges (Quarter) stood at $82000.0 in 2021, then grew by 3.66% to $85000.0 in 2022, then grew by 1.18% to $86000.0 in 2023.
  • Its Amortization of Deferred Charges was $86000.0 in Q4 2023, compared to $85000.0 in Q3 2023 and $85000.0 in Q2 2023.